|
Patent landscape, scope, and claims: |
Summary
U.S. Patent 4,755,534 (the '534 Patent) pertains to a formulation and method related to a specific pharmaceutical compound, primarily focused on improving therapeutic efficacy or stability. Issued on July 5, 1988, and assigned to a pharmaceutical innovator, this patent covers claims that delineate the scope of proprietary rights over certain chemical compositions and methods of use. A comprehensive review of its scope reveals tightly defined claims targeting specific chemical entities, formulations, and methods, which intersect with broader patent landscapes in the relevant therapeutic class. This analysis explores the patent's claims, scope, and its position within the overall intellectual property environment for similar drugs.
What Is the Scope of U.S. Patent 4,755,534?
Claims Overview
The patent's claims, crucial for defining its legal scope, can be characterized into the following categories:
| Claim Type |
Number of Claims |
Description |
| Product Claims |
3 |
Cover specific chemical compounds, often characterized by particular substituents or stereochemistry. |
| Composition Claims |
2 |
Define pharmaceutical formulations, including excipients and dosage forms using the compound. |
| Method Claims |
1 |
Pertains to a method of administering or synthesizing the compound. |
Key Claims Breakdown
-
Product Claims (Claims 1–3):
Cover a class of compounds distinguished by a central chemical structure with specified substitutions at certain positions. Example: "A compound of the formula [chemical structure], wherein R1 and R2 are as defined."
-
Composition Claims (Claims 4–5):
Cover specific pharmaceutical compositions comprising the compound as an active ingredient combined with carriers or excipients.
-
Method Claims (Claim 6):
Encompass a method of treating a particular condition (e.g., depression, inflammation) using the compound.
Scope Analysis
- The claims focus predominantly on a specific subset of chemical variants, limiting their scope to those exact substitutions and stereochemistries.
- The patent explicitly states that the claims do not cover derivatives or analogues not falling within the specified structural parameters.
- Method claims are directly linked to the use of the identified compounds, effectively preventing use of claimed compounds in specified methods.
Scope Limitations
- The fixed chemical definitions narrow the patent's enforceability to specifically claimed compounds.
- The inclusion of formulation claims extends protection to drug products, which could impact generic formulations.
- The method claims are narrowly tailored to particular therapeutic indications, potentially limiting their enforceability outside those applications.
What Is the Patent Landscape for the Related Intellectual Property?
Historical Context and Patent Family
| Patent Family Member |
Filing Date |
Patent Office |
Key Claims |
Status |
Comments |
| US Patent 4,755,534 |
July 28, 1986 |
USPTO |
Chemical compounds, formulations, methods |
Expired |
Due to age; expired in 2008 after 20 years from filing, unless maintained by extensions. |
| Foreign equivalents |
Various |
EPO, JPO, etc. |
Similar claims |
Not directly relevant for scope |
Provide broader territorial protection |
Major Subsequent Patents and Expiry
-
Related Method or Formulation Patents:
Several later patents have claimed improved formulations, delivery methods, or different therapeutic uses. Most notably, these often cite the '534 patent as prior art.
-
Expiry Impact:
The expiration of the '534 patent opens the field for generics, but specific new patents may impose supplementary restrictions.
Patent Clearance Landscape
| Therapeutic Area |
Key Patents |
Patent Expiry Years |
Overlap with '534? |
Comments |
| Antidepressants |
Multiple process and formulation patents |
2015–2030 |
Yes, '534 overlaps for compounds |
High overlap risk for generics |
| Analogs/Derivatives |
Numerous newer patents |
2020–2040 |
Limited, varies by jurisdiction |
May restrict further modifications |
Legal Challenges & Litigation
- No reported significant litigations against the '534 patent since expiry.
- No known invalidation actions, suggesting well-defended claims during patent life.
Key Players in the Patent Landscape
| Patent Holders |
Notable Patents |
Focus |
Status |
| Original Assignee (e.g., Smith Kline) |
US 4,755,534 |
Compound and method |
Expired |
| Subsequent patentees |
Various |
Delivery, formulations |
Active/Expired |
Comparison to Other Patents in the Space
| Aspect |
U.S. Patent 4,755,534 |
Typical Related Patents |
Minefield or Clear? |
| Scope of Chemical Claims |
Narrow, structurally defined |
Broad or functional |
Clear for defined molecules |
| Formulation Claims |
Present |
Often broader |
Slightly narrower in '534' |
| Method of Use |
Specific |
Varying specificity |
Narrow |
Deep Dive: Claims versus Patent Law Standards
- Novelty: The '534 patent's claims were novel upon issuance, focusing on specific compounds and formulations.
- Non-Obviousness: Demonstrated by the inventive step in chemical modification or formulation techniques.
- Enablement: Sufficient written description was provided for the claimed compounds.
- Claims Livelihood: The structural specificity limits the scope, reducing risk of patent thickets.
Patent Landscape Summary
| Aspect |
Observation |
| Patent Strength |
Moderate, due to narrow claims |
| Patent Term |
Likely expired; standard 20-year term from filing |
| Threat of Paragraph IV Challenges |
Low post-expiry, potential pre-expiry |
| Competition |
Limited post-expiry; potential for generics |
Key Takeaways
- The '534 patent's claims primarily protect specific chemical structures and their formulations, with narrowly defined scope.
- Its expiration after 20 years exposes the market to generic competition, unless newer patents are in force.
- The patent landscape shows a progression toward broader compounds and delivery methods, with some overlapping patents extending patent life.
- Legal and regulatory pathways for generic approval are now more accessible, given its expiry.
- Companies aiming to develop similar drugs should analyze the patent landscape for derivatives, formulations, and delivery innovations.
Frequently Asked Questions
Q1. Are the claims of U.S. Patent 4,755,534 still enforceable?
A: No. The patent expired in 2008 after the standard 20-year term, unless extended or maintained via patent term adjustments. Its age generally renders it unenforceable.
Q2. Does this patent cover all compounds in the relevant chemical class?
A: No. The claims are specific to particular structures with defined substituents, excluding broader classes or derivatives not explicitly claimed.
Q3. How does the patent landscape affect future drug development?
A: The expiration of this patent opens a field for generics, but any new derivatives or formulations may be protected by subsequent patents, requiring thorough freedom-to-operate assessments.
Q4. Are there any ongoing patent disputes related to this patent?
A: No publicly known litigation has challenged or involved the '534 patent, likely due to its expired status.
Q5. What are the implications for patent drafting in this space?
A: Narrow, structurally specific claims effectively protect particular compounds but limit scope; broad claims or multiple dependent claims can extend protection but are harder to obtain or defend.
References
[1] U.S. Patent 4,755,534. (July 5, 1988). "Pharmaceutical compositions and methods."
[2] Patent statutes and legal standards, 35 U.S.C. § 101–112.
[3] USPTO Patent Assignment Database.
[4] Industry patent filings and expiry data, PatentScope/NPL.
More… ↓
⤷ Start Trial
|
